drugset / Trial / NCT01505439

A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence

NCT01505439

Phase 4 Completed 311 enrolled Jeong Gu Lee Astellas Pharma Korea, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

This study is to investigate the effects of solifenacin on urgency urinary incontinence symptoms and incontinence quality-of-life (I-QoL) in female patients with clinically significant stress urinary incontinence accompanied by urgency urinary incontinence.

Timeline

Start
2011-06
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Solifenacin Small molecule Oral